|
|
|
|
LEADER |
03109nam a22004815i 4500 |
001 |
978-3-030-23906-0 |
003 |
DE-He213 |
005 |
20210620012353.0 |
007 |
cr nn 008mamaa |
008 |
190802s2019 gw | s |||| 0|eng d |
020 |
|
|
|a 9783030239060
|9 978-3-030-23906-0
|
024 |
7 |
|
|a 10.1007/978-3-030-23906-0
|2 doi
|
050 |
|
4 |
|a R856-R857
|
072 |
|
7 |
|a MQW
|2 bicssc
|
072 |
|
7 |
|a MED003040
|2 bisacsh
|
072 |
|
7 |
|a MQW
|2 thema
|
082 |
0 |
4 |
|a 610.28
|2 23
|
245 |
1 |
0 |
|a 3D Bioprinting in Medicine
|h [electronic resource] :
|b Technologies, Bioinks, and Applications /
|c edited by Murat Guvendiren.
|
250 |
|
|
|a 1st ed. 2019.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2019.
|
300 |
|
|
|a XIII, 209 p. 38 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Chapter 1 - 3D Bioprinting Technologies -- Chapter 2 - Materials as Bioinks and Bioink Design -- Chapter 3 - Potential Clinical Applications of Three-Dimensional Bioprinting -- Chapter 4 - Bioprinting Vasculature -- Chapter 5 - 3D bioprinting in clinical cardiovascular medicine -- Chapter 6 - Understanding Cancer Cell Behavior Through 3D Printed Bone Microenvironments -- Chapter 7 - Three-Dimensional Bioprinting: Safety, Ethical and Regulatory Considerations -- Index.
|
520 |
|
|
|a This book provides current and emerging developments in bioprinting with respect to bioprinting technologies, bioinks, applications, and regulatory pathways. Topics covered include 3D bioprinting technologies, materials such as bioinks and bioink design, applications of bioprinting complex tissues, tissue and disease models, vasculature, and musculoskeletal tissue. The final chapter is devoted to clinical applications of bioprinting, including the safety, ethical, and regulatory aspects. This book serves as a go-to reference on bioprinting and is ideal for students, researchers and professionals, including those in academia, government, the medical industry, and healthcare.
|
650 |
|
0 |
|a Biomedical engineering.
|
650 |
|
0 |
|a Biomaterials.
|
650 |
1 |
4 |
|a Biomedical Engineering/Biotechnology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B24000
|
650 |
2 |
4 |
|a Biomaterials.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/Z13000
|
650 |
2 |
4 |
|a Biomedical Engineering and Bioengineering.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/T2700X
|
700 |
1 |
|
|a Guvendiren, Murat.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030239053
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030239077
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030239084
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-23906-0
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|